Management of device embolisation during left atrial appendage closure
EuroIntervention · 2025
DOI: 10.4244/eij-d-24-00812 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift EuroIntervention, 2025. Verfasst von Joelle Kefer und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Cliniques universitaires Saint-Luc et Pôle de Recherche Cardiovasculaire, Institut de Recherche Expérimentale et Clinique (IR…. Hauptthemen laut MEDLINE: Atrial Appendage, Atrial Fibrillation, Cardiac Catheterization, Device Removal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Percutaneous left atrial appendage closure (LAAC) is increasingly used as a valuable intervention to prevent cardioembolic stroke among patients with atrial fibrillation who are poor candidates for long-term anticoagulation. The safety of the procedure has significantly improved over time; nevertheless, device embolisation remains a severe complication that still occurs in around 0.1% of cases. Its management must be rapid and effective in order to reduce mortality. The anatomical location of the embolised device dictates the technical approach for retrieval and has a major impact on the clinical outcome of patients. Percutaneous recapture is the main approach in case of an aortic or left atrial embolisation, while emergent surgery should be performed if the device becomes entangled in the mitral apparatus with poor haemodynamics unsolved by transcatheter device mobilisation into the left ventricular (LV) cavity. In cases of LV embolisation and stable haemodynamics, a transfemoral or transseptal retrieval may be attempted. The equipment for retrieval is key to success: all cath labs performing LAAC procedures should be equipped with minimum 16 Fr sheaths, steerable sheaths, single-loop snares and grasping tool devices. This paper includes a summary of the European Left Atrial Appendage Closure Club consensus recommendations for LAAC device embolisation management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Cardiology, Cliniques universitaires Saint-Luc et Pôle de Recherche Cardiovasculaire, Institut de Recherche Expérimentale et Clinique (IREC), Université Catholique de Louvain (UCLouvain), Brussels, Belgium.
- The Heart Center, Rigshospitalet, Copenhagen, Denmark.
- Division of Cardiology, Centre Hospitalier Universitaire de Charleroi, Charleroi, Belgium.
- Cardiology Department, Institut Clinic Cardiovascular, Hospital Clínic de Barcelona, Barcelona, Spain.
- Ospedale del Cuore, Fondazione CNR Regione Toscana, Massa, Italy.
- Department of Cardiology, University Hospital of Salamanca, IBSAL, CIBER-CV, Salamanca, Spain.
Zitieren
APA
Kefer, J., De Backer, O., Aminian, A., Freixa, X., Berti, S., Cruz-Gonzalez, I., Räber, L., Wunderlich, N., Garot, P., Nielsen-Kudsk, J. E., & Behalf Of The European Left Atrial Appendage Closure Club Elaacc, O. (2025). Management of device embolisation during left atrial appendage closure. EuroIntervention. https://doi.org/10.4244/eij-d-24-00812
Vancouver
Kefer J, De Backer O, Aminian A, Freixa X, Berti S, Cruz-Gonzalez I, et al. Management of device embolisation during left atrial appendage closure. EuroIntervention. 2025. doi:10.4244/eij-d-24-00812
BibTeX
@article{Kefer2025,
author = {Kefer, Joelle and De Backer, Ole and Aminian, Adel and Freixa, Xavier and Berti, Sergio and Cruz-Gonzalez, Ignacio and Räber, Lorenz and Wunderlich, Nina and Garot, Philippe and Nielsen-Kudsk, Jens Erik and Behalf Of The European Left Atrial Appendage Closure Club Elaacc, On},
title = {Management of device embolisation during left atrial appendage closure},
journal = {EuroIntervention},
year = {2025},
doi = {10.4244/eij-d-24-00812}
}
EUVIMED